10x Genomics (TXG) Equity Ratio (2018 - 2025)
Historic Equity Ratio for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to 0.76.
- 10x Genomics' Equity Ratio fell 107.84% to 0.76 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.76, marking a year-over-year decrease of 107.84%. This contributed to the annual value of 0.76 for FY2025, which is 107.84% down from last year.
- 10x Genomics' Equity Ratio amounted to 0.76 in Q4 2025, which was down 107.84% from 0.76 recorded in Q3 2025.
- 10x Genomics' Equity Ratio's 5-year high stood at 0.81 during Q3 2021, with a 5-year trough of 0.76 in Q3 2025.
- For the 5-year period, 10x Genomics' Equity Ratio averaged around 0.78, with its median value being 0.78 (2022).
- Per our database at Business Quant, 10x Genomics' Equity Ratio skyrocketed by 1954.58% in 2021 and then tumbled by 360.12% in 2022.
- Over the past 5 years, 10x Genomics' Equity Ratio (Quarter) stood at 0.8 in 2021, then decreased by 2.42% to 0.78 in 2022, then fell by 1.95% to 0.77 in 2023, then rose by 0.68% to 0.77 in 2024, then fell by 1.08% to 0.76 in 2025.
- Its last three reported values are 0.76 in Q4 2025, 0.76 for Q3 2025, and 0.79 during Q2 2025.